Statins induce skeletal muscle atrophy via GGPP depletion-dependent myostatin overexpression in skeletal muscle and brow
- PDF / 7,264,727 Bytes
- 20 Pages / 547.087 x 737.008 pts Page_size
- 93 Downloads / 228 Views
ORIGINAL ARTICLE
Statins induce skeletal muscle atrophy via GGPP depletion-dependent myostatin overexpression in skeletal muscle and brown adipose tissue Lai Wang & Zu-Guo Zheng & Lingchang Meng & Lijun Zhu & Ping Li & Jun Chen & Hua Yang
Received: 12 February 2020 / Accepted: 16 September 2020 # Springer Nature B.V. 2020
Abstract Myopathy is the major adverse effect of statins. However, the underlying mechanism of statininduced skeletal muscle atrophy, one of statin-induced myopathy, remains to be elucidated. Myostatin is a negative regulator of skeletal muscle mass and functions. Whether myostatin is involved in statin-induced skeletal muscle atrophy remains unknown. In this study, we uncovered that simvastatin administration increased Lai Wang and Zu-Guo Zheng contributed equally to this work. Electronic supplementary material The online version of this article (https://doi.org/10.1007/s10565-020-09558-w) contains supplementary material, which is available to authorized users. L. Wang : Z.
Data Loading...
